Press Releases

Omega 3 Supplements Market Opportunities & Forecast 2022-2030

The global omega 3 supplements market size is expected to be worth around US$ 15.20 billion by 2030, according to a new report by Vision Research Reports.

The global omega 3 supplements market size was valued at US$ 6.50 billion in 2020 and is anticipated to grow at a CAGR of 9.6% during forecast period 2021 to 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38812

Report Coverage

Report Scope Details
Market Size US$ 15.20 Bn by 2030
Growth Rate CAGR of 9.6% From 2021 to 2030
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Source, form, functionality, end user, distribution channel
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Nordic Naturals, Inc.; NutriGold Inc.; Reckitt Benckiser Group plc; Pharma Nord B.V; i-Health, Inc.; Aker BioMarine AS; Luhua Biomarine (Shandong) Co., Ltd.; Pharmavite LLC; KD Pharma Group; NOW Foods; GlaxoSmithKline plc; Natrol LLC; Carlson Laboratories; OmegaBrite; Optimum Nutrition, Inc.; VAYA Pharma; Vital Choice Wild Seafood & Organics, SPC; Bionova; The Nature’s Bounty Co.; Arkopharma

Growth Factors

A sedentary lifestyle has resulted in a rising number of chronic diseases, which is expected to propel the product demand. The omega-3 fatty acids aid in decreasing the risk of abnormal heartbeats or arrhythmias, which can even cause sudden death of the patient. It also helps in reducing triglyceride levels, slowing the growth rate of atherosclerotic plaque, and lowering blood pressure levels. Consumers are increasingly shifting to healthier alternatives while adopting preventive care as a necessary tool to help them lead a better lifestyle. Thus, omega 3 supplements are being increasingly consumed as they are a rich source of vitamins, proteins, minerals and render benefits to diseases, such as cancer, asthma, depression, and others.

By Source Analysis

Fish oil-based supplements led the market and accounted for more than 64.1% share of the global revenue in 2020. The availability of various types of fish, which contain different vitamins, is propelling omega-3 supplement manufacturers to offer diversified products. Increasing environmental, metal, & hazardous pollutants in fish are making them toxic for utilization, which is expected to restrain the growth of the segment.

increasing regulations on fishing activities to protect the fish species are expected to affect the raw material supply for the industry. The rising consumer inclination towards plant-based alternatives is expected to drive the demand for algae oil-based supplements.

By Form Analysis

Soft gels led the form segment with a share of 42.3% in the global market in 2020. Soft gels are an oral dosage form that consists of a gelatin-based shell surrounding a liquid fill. Soft gels are easier to swallow as compared to tablets and capsules as they do not have an unpleasant odor and are tasteless.

Apart from omega-3 supplements, other dietary supplements including vitamin A, D3, & E, carotenoids, lycopene, and omega-3 fatty acids are also offered in soft gel form. The application of soft gels is projected to witness significant growth owing to their smooth texture and taste masking capabilities.

Plant-based casing materials are expected to witness a considerable demand due to the growing vegan population across the globe. Gummies, similar to candies, are a chewable form of omega-3 supplements that are enriched with nutrients.

By Functionality Analysis

Cardiovascular health led the market and accounted for a 38.4% share of the global revenue in 2020. Concerning cardiovascular disease prevention, omega-3 fatty acids help maintain HDL cholesterol, stabilize heart rhythms, reduce harmful LDL cholesterol, and lower blood pressure. All these health benefits are expected to drive the product demand in the cardiovascular health segment.

This trend is expected to drive the product demand for the treatment of coronary heart diseases, hypertension, and cholesterol. The brain, nervous system, and mental health segment is expected to register the second-fastest CAGR over the forecast period.

By Distribution Channel Analysis

The Over-The-Counter (OTC) distribution channel segment led the market and accounted for a 75.9% share of the global revenue in 2020. Initiatives related to the introduction of favorable policies, along with the infrastructural development in the healthcare sector by most governments worldwide, are projected to influence the expansion and popularity of omega 3 supplements through the OTC channel.

The cost-effectiveness and convenience of direct purchase are expected to create various opportunities for product manufacturers. Strict regulations by the governing bodies and less awareness among individuals are expected to augment the product sales through the prescribed distribution channel.

By End-user Analysis

The adult end-user segment accounted for the highest revenue share of over 43% in 2020. Growing consumption of omega 3 supplements among working individuals to maintain a healthy lifestyle is projected to remain a key driving factor for the segment.

The children segment is expected to witness significant growth owing to the increasing inclination towards maintaining optimal health along with high purchasing power and willingness to spend on health and wellness products.

By Regional  Analysis

North America dominated the market and accounted for 37.7% share of the global revenue in 2020. Increased cases of obesity and lifestyle-related diseases on account of unhealthy dietary habits and availability of several processed and Ready-To-Eat (RTE) foods.

Cardiovascular health is one of the primary application segments of omega 3 supplements as Coronary Heart Disease (CHD) is a primary cause of death among several men and women in North America.

products, such as fortified foods and dietary supplements enriched with omega fatty acids, are expected to have a high demand in the regional market. Asia Pacific is anticipated to witness significant growth on account of the rising expenditure on health-enhancing products due to increasing sports activities.

Key Players

  • Nordic Naturals, Inc.
  • NutriGold Inc.
  • Reckitt Benckiser Group plc
  • Pharma Nord B.V
  • i-Health, Inc.
  • Aker BioMarine AS
  • Luhua Biomarine (Shandong) Co., Ltd.
  • Pharmavite LLC
  • KD Pharma Group
  • NOW Foods
  • GlaxoSmithKline plc
  • Natrol LLC
  • Carlson Laboratories
  • OmegaBrite
  • Optimum Nutrition, Inc.
  • VAYA Pharma
  • Vital Choice Wild Seafood & Organics, SPC
  • Bionova
  • The Nature’s Bounty Co.
  • Arkopharma

Market Segmentation

  • By Source
    • Fish Oil
    • Krill Oil
    • Algae Oil
    • Others
  • By Form
    • Tablets
    • Capsules
    • Soft Gels
    • Others
  • By Functionality
    • Cardiovascular Health
    • Brain, Nervous System & Mental Health
    • Eye Diseases
    • Diabetes
    • Others
  • By End-user
    • Adults
    • Geriatric
    • Pregnant Women
    • Children
    • Infants
  • By Distribution Channel
    • OTC
      • Supermarkets/ Hypermarkets/Food Stores
      • Drug Stores & Pharmacies
      • Online Retailers
      • Others
    • Prescribed
  • Regional
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • U.K.
      • France
      • The Netherlands
      • Italy
      • Spain
      • Norway
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • New Zealand
    • Central & South America
      • Brazil
      • Argentina
    • Middle East & Africa
      • UAE

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38812

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Omega 3 Supplements Market, By Source

7.1.  Omega 3 Supplements Market, by Source, 2021-2030

7.1.1.    Fish Oil

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Krill Oil

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Algae Oil

7.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Omega 3 Supplements Market, By Form

8.1.  Omega 3 Supplements Market, by Form, 2021-2030

8.1.1.    Tablets

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Capsules

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Soft Gels

8.1.3.1.        Market Revenue and Forecast (2017-2030)

8.1.4.    Others

8.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Omega 3 Supplements Market, By Functionality

9.1.  Omega 3 Supplements Market, by Functionality, 2021-2030

9.1.1.    Cardiovascular Health

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Brain, Nervous System & Mental Health

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Eye Diseases

9.1.3.1.        Market Revenue and Forecast (2017-2030)

9.1.4.    Diabetes

9.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Omega 3 Supplements Market, By End-user

10.1.        Omega 3 Supplements Market, by End-user, 2021-2030

10.1.1.  Adults

10.1.1.1.      Market Revenue and Forecast (2017-2030)

10.1.2.  Geriatric

10.1.2.1.      Market Revenue and Forecast (2017-2030)

10.1.3.  Pregnant Women

10.1.3.1.      Market Revenue and Forecast (2017-2030)

10.1.4.  Children

10.1.4.1.      Market Revenue and Forecast (2017-2030)

10.1.5.  Infants

10.1.5.1.      Market Revenue and Forecast (2017-2030)

Chapter 11.      Global Omega 3 Supplements Market, By Distribution Channel

11.1.        Omega 3 Supplements Market, by Distribution Channel, 2021-2030

11.1.1.  OTC

11.1.1.1.      Market Revenue and Forecast (2017-2030)

11.1.2.  Prescribed

11.1.2.1.      Market Revenue and Forecast (2017-2030)

Chapter 12.      Global Omega 3 Supplements  Market, Regional Estimates and Trend Forecast

12.1.        North America

12.1.1.  Market Revenue and Forecast, by Source (2017-2030)

12.1.2.  Market Revenue and Forecast, by Form (2017-2030)

12.1.3.  Market Revenue and Forecast, by Functionality (2017-2030)

12.1.4.  Market Revenue and Forecast, by End-user (2017-2030)

12.1.5.  Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.1.6.  U.S.

12.1.6.1.      Market Revenue and Forecast, by Source (2017-2030)

12.1.6.2.      Market Revenue and Forecast, by Form (2017-2030)

12.1.6.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.1.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.1.6.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.1.7.  Rest of North America

12.1.7.1.      Market Revenue and Forecast, by Source (2017-2030)

12.1.7.2.      Market Revenue and Forecast, by Form (2017-2030)

12.1.7.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.1.7.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.1.7.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.2.        Europe

12.2.1.  Market Revenue and Forecast, by Source (2017-2030)

12.2.2.  Market Revenue and Forecast, by Form (2017-2030)

12.2.3.  Market Revenue and Forecast, by Functionality (2017-2030)

12.2.4.  Market Revenue and Forecast, by End-user (2017-2030)

12.2.5.  Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.2.6.  UK

12.2.6.1.      Market Revenue and Forecast, by Source (2017-2030)

12.2.6.2.      Market Revenue and Forecast, by Form (2017-2030)

12.2.6.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.2.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.2.6.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.2.7.  Germany

12.2.7.1.      Market Revenue and Forecast, by Source (2017-2030)

12.2.7.2.      Market Revenue and Forecast, by Form (2017-2030)

12.2.7.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.2.7.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.2.7.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.2.8.  France

12.2.8.1.      Market Revenue and Forecast, by Source (2017-2030)

12.2.8.2.      Market Revenue and Forecast, by Form (2017-2030)

12.2.8.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.2.8.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.2.8.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.2.9.  Rest of Europe

12.2.9.1.      Market Revenue and Forecast, by Source (2017-2030)

12.2.9.2.      Market Revenue and Forecast, by Form (2017-2030)

12.2.9.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.2.9.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.2.9.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.3.        APAC

12.3.1.  Market Revenue and Forecast, by Source (2017-2030)

12.3.2.  Market Revenue and Forecast, by Form (2017-2030)

12.3.3.  Market Revenue and Forecast, by Functionality (2017-2030)

12.3.4.  Market Revenue and Forecast, by End-user (2017-2030)

12.3.5.  Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.3.6.  India

12.3.6.1.      Market Revenue and Forecast, by Source (2017-2030)

12.3.6.2.      Market Revenue and Forecast, by Form (2017-2030)

12.3.6.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.3.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.3.6.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.3.7.  China

12.3.7.1.      Market Revenue and Forecast, by Source (2017-2030)

12.3.7.2.      Market Revenue and Forecast, by Form (2017-2030)

12.3.7.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.3.7.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.3.7.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.3.8.  Japan

12.3.8.1.      Market Revenue and Forecast, by Source (2017-2030)

12.3.8.2.      Market Revenue and Forecast, by Form (2017-2030)

12.3.8.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.3.8.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.3.8.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.3.9.  Rest of APAC

12.3.9.1.      Market Revenue and Forecast, by Source (2017-2030)

12.3.9.2.      Market Revenue and Forecast, by Form (2017-2030)

12.3.9.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.3.9.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.3.9.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.4.        MEA

12.4.1.  Market Revenue and Forecast, by Source (2017-2030)

12.4.2.  Market Revenue and Forecast, by Form (2017-2030)

12.4.3.  Market Revenue and Forecast, by Functionality (2017-2030)

12.4.4.  Market Revenue and Forecast, by End-user (2017-2030)

12.4.5.  Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.4.6.  GCC

12.4.6.1.      Market Revenue and Forecast, by Source (2017-2030)

12.4.6.2.      Market Revenue and Forecast, by Form (2017-2030)

12.4.6.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.4.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.4.6.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.4.7.  North Africa

12.4.7.1.      Market Revenue and Forecast, by Source (2017-2030)

12.4.7.2.      Market Revenue and Forecast, by Form (2017-2030)

12.4.7.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.4.7.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.4.7.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.4.8.  South Africa

12.4.8.1.      Market Revenue and Forecast, by Source (2017-2030)

12.4.8.2.      Market Revenue and Forecast, by Form (2017-2030)

12.4.8.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.4.8.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.4.8.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.4.9.  Rest of MEA

12.4.9.1.      Market Revenue and Forecast, by Source (2017-2030)

12.4.9.2.      Market Revenue and Forecast, by Form (2017-2030)

12.4.9.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.4.9.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.4.9.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.5.        Latin America

12.5.1.  Market Revenue and Forecast, by Source (2017-2030)

12.5.2.  Market Revenue and Forecast, by Form (2017-2030)

12.5.3.  Market Revenue and Forecast, by Functionality (2017-2030)

12.5.4.  Market Revenue and Forecast, by End-user (2017-2030)

12.5.5.  Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.5.6.  Brazil

12.5.6.1.      Market Revenue and Forecast, by Source (2017-2030)

12.5.6.2.      Market Revenue and Forecast, by Form (2017-2030)

12.5.6.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.5.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.5.6.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.5.7.  Rest of LATAM

12.5.7.1.      Market Revenue and Forecast, by Source (2017-2030)

12.5.7.2.      Market Revenue and Forecast, by Form (2017-2030)

12.5.7.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.5.7.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.5.7.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

Chapter 13.  Company Profiles

13.1.              Nordic Naturals, Inc.

13.1.1.  Company Overview

13.1.2.  Product Offerings

13.1.3.  Financial Performance

13.1.4.  Recent Initiatives

13.2.              NutriGold Inc.

13.2.1.  Company Overview

13.2.2.  Product Offerings

13.2.3.  Financial Performance

13.2.4.  Recent Initiatives

13.3.              Reckitt Benckiser Group plc

13.3.1.  Company Overview

13.3.2.  Product Offerings

13.3.3.  Financial Performance

13.3.4.  Recent Initiatives

13.4.              Pharma Nord B.V

13.4.1.  Company Overview

13.4.2.  Product Offerings

13.4.3.  Financial Performance

13.4.4.  Recent Initiatives

13.5.              i-Health, Inc.

13.5.1.  Company Overview

13.5.2.  Product Offerings

13.5.3.  Financial Performance

13.5.4.  Recent Initiatives

13.6.              Aker BioMarine AS

13.6.1.  Company Overview

13.6.2.  Product Offerings

13.6.3.  Financial Performance

13.6.4.  Recent Initiatives

13.7.              Luhua Biomarine (Shandong) Co., Ltd.

13.7.1.  Company Overview

13.7.2.  Product Offerings

13.7.3.  Financial Performance

13.7.4.  Recent Initiatives

13.8.              Pharmavite LLC

13.8.1.  Company Overview

13.8.2.  Product Offerings

13.8.3.  Financial Performance

13.8.4.  Recent Initiatives

13.9.              KD Pharma Group

13.9.1.  Company Overview

13.9.2.  Product Offerings

13.9.3.  Financial Performance

13.9.4.  Recent Initiatives

13.10.           NOW Foods

13.10.1.               Company Overview

13.10.2.               Product Offerings

13.10.3.               Financial Performance

13.10.4.               Recent Initiatives

Chapter 14.  Research Methodology

14.1.              Primary Research

14.2.              Secondary Research

14.3.              Assumptions

Chapter 15.  Appendix

15.1.              About Us

15.2.              Glossary of Terms

 

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38812

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com

Show More

Related Articles

Back to top button